A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Clinical trial NCT06074562 · COMPLETED

Trial details

NCT number: NCT06074562
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathy

Start date: 2023-10-05
Primary completion: 2025-06-11
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.